Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
National Cancer Institute (NCI)
Fred Hutch/University of Washington Cancer Consortium

      This randomized clinical trial studies different chemotherapies in treating patients with
      myelodysplastic syndrome before donor stem cell transplant. Giving chemotherapy before a
      donor stem cell transplant helps stop the growth of cancer cells in the bone marrow,
      including normal blood-forming cells (stem cells) and cancer cells, and may prevent the
      myelodysplastic syndrome from coming back after the transplant. When the healthy stem cells
      from a donor are infused into the patient they may help the patient's bone marrow make stem
      cells, red blood cells, white blood cells, and platelets.
    
Drug